Canadian Psychiatric Association
 

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)


Guest Editorial
From Counting to Understanding: The Evolving Epidemiologic Approach to Dementia

Ian McDowell, PhD

(PDF)


In Review
More Than the Epidemiology of Alzheimer’s Disease: Contributions of the Canadian Study of Health and Aging

Joan Lindsay, Elizabeth Sykes, Ian McDowell, René Verreault, Danielle Laurin

(PDF)

Alzheimer’s Disease, Genes, and Environment: The Value of International Studies
Hugh C Hendrie, Kathleen S Hall, Adesola Ogunniyi, Sujuan Gao

(PDF)


Original Research
Hidden Cardiac Lesions and Psychotropic Drugs as a Possible Cause of Sudden Death in Psychiatric Patients: A Report of 14 Cases and Review of the Literature

Dominique Frassati, Alain Tabib, Bernard Lachaux, Natalie Giloux, Jean Daléry, François Vittori, Dorothée Charvet, Cécile Barel, Bernard Bui-Xuan, Rachel Mégard, Louis Pierre Jenoudet, Jacques Descotes, Thierry Vial, Quadiri Timour

(PDF)

The 5-Factor Model of Personality and Antidepressant Medication Compliance
Nicole L Cohen, Erin C Ross, R Michael Bagby, Peter Farvolden, Sidney H Kennedy

(PDF)

Social, Demographic, and Clinical Factors Related to Disruptive Behaviour in Hospital
Andrea K Boggild, Marnin J Heisel, Paul S Links

(PDF)

The Course of Depressive Illness in General Practice
Frédéric Limosin, PhD, Jean-Yves Loze, Myriam Zylberman-Bouhassira, Mark E Schmidt, Eléna Perrin, Frédéric Rouillon

(PDF)


Review Paper
Prevalence and Incidence Studies of Mood Disorders: A Systematic Review of the Literature

Paul Waraich, Elliot M Goldner, Julian M Somers, Lorena Hsu

(PDF)


Brief Communication
Bupropion Sustained Release Treatment Reduces Fatigue in Cancer Patients

Jodi L Cullum, Agnieszka E Wojciechowski, Guy Pelletier, J Steven A Simpson

(PDF)

Patient Factors Associated With Missed Appointments in Persons With Schizophrenia
Shalom Coodin, Douglas Staley, Barb Cortens, Rob Desrochers, Sandy McLandress

(PDF)


Book Reviews
(PDF)

The Treatment of Anxiety Disorders: Clinical Guides and Patient Manuals. 2nd ed Reviewed by
Richard Swinson, MD


Cognitive-Behavioral Group Therapy for Social Phobia: Basic Mechanisms and Clinical Strategies
Reviewed by
Michael Van Ameringen, MD, FRCPC


Letters to the Editor
(PDF)

Aripirazole–Olanzapine Combination for Treatment of Schizophrenia

Improvement of Torticollis With Quetiapine in a Schizophrenia Patient

Internalizing Antecedents of Conduct Disorder

Travel Time and the Use of Psychiatric Outpatient Clinic Services in Coastal Northern Norway

Respiratory Panic Disorder Treatment With Clonidine

Review Paper

Prevalence and Incidence Studies of Mood Disorders: A Systematic Review of the Literature

Paul Waraich, MHSc, MD1, Elliot M Goldner, MHSc, MD2, Julian M Somers, MSc, PhD1, Lorena Hsu, MSc3

 

This is the second in a series of papers that present systematic reviews of the prevalence and incidence of psychiatric disorders drawn from
studies published in English literature in the years 1980 to 2000. The series discusses the implications of these epidemiologic findings to mental health policy and practice. 

Objective: To present the results of a systematic review of literature published between January 1, 1980, and December 31, 2000, that reports findings on the prevalence and incidence of mood disorders in both general population and primary care settings.

Method: We conducted a literature search of epidemiologic studies of mood disorders, using Medline and HealthSTAR databases and canvassing English-language publications. Eligible publications were restricted to studies that examined subjects aged at least 15 years and over. We used a set of predetermined inclusion and exclusion criteria to identify relevant studies. We extracted and analyzed prevalence and incidence data for heterogeneity. 

Results: Of general population studies, a total of 18 prevalence and 5 incidence studies met eligibility criteria. We found heterogeneity across 1-year and lifetime prevalence of major depressive disorder (MDD), dysthymic disorder, and bipolar I disorder. The corresponding pooled rates for 1-year prevalence were 4.1 per 100, 2.0 per 100, and 0.72 per 100, respectively. For lifetime prevalence, the corresponding pooled rates were 6.7 per 100, 3.6 per 100, and 0.8 per 100, respectively. Significant variation was observed among 1-year incidence rates of MDD, with a corresponding pooled rate of 2.9 per 100. 

Conclusions: The prevalence of mood disorders reported in high-quality studies is generally lower than rates commonly reported in the general psychiatric literature. When controlled for common methodological confounds, variation in prevalence rates persists across studies and deserves continued study. Methodological variation among studies that have examined the prevalence of depression in primary health care services is so large that comparative analyses cannot be achieved. 

(Can J Psychiatry 2004;49:124–138) 

Click here for author affiliations.

Click here for research funding and support.

Clinical Implications

  • If health planners, clinicians, and researchers have been using commonly reported prevalence rates to estimate the burden of disease as a result of mood disorders, they may need to revise these estimates downward. 

  • The prevalence of depression in primary care should be reexamined with standardized methodologies.

  • The persistent variation in the incidence and prevalence of mood disorders warrants further investigation. 

Limitations

  • The best-estimate rates reported in this study should not be reported without their confidence intervals, because significant heterogeneity exists among studies.

  • This study reviews English-only reports between 1980 and 2000 and may have missed some high-quality studies.

  • The preliminary analysis of variation in rates presented in this study should be seen as hypothesis-generating. Further analysis must be cautious of ecological fallacy.


Key Words
: mood disorders, major depression, dysthymia, bipolar disorders, prevalence, incidence, systematic review

Résumé :Études de la prévalence et de l’incidence des troubles de l’humeur : un examen méthodique de la documentation

The diagnostic category of mood disorders is among the most prevalent of all mental health diagnoses (1–3). (For a definition of prevalence and incidence, refer to Goldner and colleagues; 4). Conducting a review of this category of mental disorders is challenging for several reasons. One challenge is that the various conditions that comprise this grouping of disorders can be quite disparate: some are transient, others are chronic or recurrent. Therefore, it is difficult to speak in generalities about the characteristics of mood disorders. Although most mood disorders result in some degree of temporary cognitive difficulty and mild deficits in attention or concentration, some forms of mood disorders are associated with profound cognitive and perceptual disturbance with delusional and hallucinatory features. Another set of challenges to reviewing the epidemiology of mood disorders involves the nosological frameworks and systems of psychiatric nomenclature currently in use (5,6). Mood disorders are constructs (that is, entities that cannot be directly measured or observed) developed through inference, hypothesis, deduction, and conjecture (1). Although mood disorders are described as taxonic (that is, defined in categorical terms) in current diagnostic nosological systems, some of their features may be more usefully conceptualized in dimensional terms (7). Given the uncertainties of our diagnostic constructs for mood disorders, previous reviews unsurprisingly report highly variable rates for all mood disorders (3,8–12) (Table 1). In addition, individuals may alternate between various mood disorders during their lifetime (13), making it difficult to determine the onset and cessation of disease episodes.

Table 1  Variation of rates of mood disorders in selected review studies

Disorder 

Review study 

Prevalence rate (per 100) 

Incidence 

 

 

Point 

1-year 

Lifetime 

 

Depression 

Bland (3) 

— 

0.6 to 7.0 

0.9 to 16.1 

— 

 

Wittchen and others (8) 

1.5 to 4.0 

2.6 to 9.8 

4.4 to 18 

— 

 

Boyd and Weissman (9) 

— 

— 

— 

104 to 519 per 100 000 

Depression in primary care 

Lemelin and others (10) 

l Self-report 

l Interview-        based 

 

4.8 to 8.6 

9.0 to 30.0 

 

— 

— 

 

— 

— 

 

— 

— 

Dysthymia 

Wittchen and others (8) 

1.2 to 3.9 

2.3 to 4.6 

3.1 to 3.9 

— 

 

Bland (3) 

— 

— 

4.1 to 8.6 

— 

Bipolar I disorder 

Wittchen and others (8) 

0.1 to 2.3 

1.0 to 1.7 

0.6 to 3.3 

— 

 

Weissman and others (11) 

— 

0.3 to 1.5 

— 

 

Bebbington and Ramana (12) 

— 

— 

2.6 to 20.8 per 100 000 yearly 


This review addresses some of the challenges described above by presenting the results of a systematic review of literature published between January 1, 1980, and December 31, 2000, that reports findings of the prevalence and incidence of mood disorders in both general population and primary care settings. We examine the variability of the rates of disorders across studies and attempt to determine how much of this variance can be accounted for by various factors, using hetero- geneity analysis. This technique should decrease the variance associated with heterogeneous study methods and diagnostic constructs and subsequently provide a more robust estimate of the variation in rates of disorders.

We focus our discussion on the mood disorders that have been most extensively examined in epidemiologic studies: major depressive disorder (MDD), dysthymia, and bipolar I disorder (BD I). MDD has been found to be one of the most prevalent mood disorders in previous reviews (Table 1). It is important not only because of its prevalence but also because of its associated disability. The Global Burden of Disease study found that the disability associated with MDD is surpassed only by that associated with ischemic heart disease in industrialized countries (14). Previous reports have also highlighted recent trends toward an increasing prevalence of depression. This may mean that depression will be even more of a burden on society in future years (14,15). We selected the epidemiology of MDD in primary care as an additional topic of interest for this review. Several jurisdictions are currently attempting to address care gaps in the management of depression in primary care, such as the low detection rate by primary care physicians (16). Establishing robust estimates of the prevalence of depression in primary care will inform these policy initiatives.

Dysthymia is characterized by chronic low-grade depressive symptoms and can be particularly disabling when it is comorbid with other mood disorders, such as MDD. About 70% of those with dysthymia may eventually go on to develop MDD (13). Relative to other mood disorders, research on the epidemiology of dysthymia has been scarce (3); however, several recent studies have examined this disorder in more detail (17–19). BD I, also known as manic-depressive disorder, may be the most disabling of mood disorders (14). About 10% of people with MDD eventually develop BD, which makes studying the epidemiology of this disorder difficult (13).

Methods

The methods employed in this review have been presented in more detail elsewhere (4). We searched the Medline and HealthSTAR databases for relevant studies, using the key indexing terms epidemiology, prevalence, and incidence, combined with the search terms mental disorders, mood disorders, depressive disorders, major depression, dysthymia, and bipolar disorders. We limited the search to English-language studies published between January 1, 1980, and December 31, 2000. Reference lists of relevant primary and review articles identified were also searched.

General population prevalence and incidence studies were eligible for inclusion if they were community surveys using probability sampling techniques. For primary care studies, those that randomly or consecutively sampled a population of primary care attendees for a given period were included. Eligible publications were restricted to studies having sample sizes of 450 or over. We chose this number as the lower limit of sample size based on preliminary calculations (using the formula in Kelsey and colleagues; 20, p 282) that demonstrated adequate error rates for a range of expected prevalence rates. Studies were also eligible for inclusion if they examined age ranges covering the adult population. Only studies using operationalized diagnostic criteria and case identification based on either standardized instruments or clinician diagnosis were included. Prevalence data, including overall, sex-specific, and age-specific rates, were extracted from eligible studies.

We conducted qualitative analyses of variables related to methodology to summarize and elucidate any observed differences between rates. As well, we pooled each set of rates according to a Bayesian approach to metaanalysis, using the Fastpro software program. Readers interested in a more detailed discussion of this approach should refer to Eddy and colleagues (21). We analyzed each of the pooled rates for heterogeneity, using chi-square tests according to Fleiss’ method (22).

Results

Description of Studies
General Population Studies. From the citations and abstracts generated from the initial electronic search, we identified 38 prevalence and 12 incidence studies potentially meeting our inclusion criteria, in addition to 8 review papers. The full texts of these articles were retrieved. All reference lists of identified studies and reviews were searched, generating an additional 39 prevalence and 15 incidence studies, for which full-text articles were obtained.

Of the 77 prevalence studies for which full-text articles were reviewed, 42 studies were excluded: 30 studies did not meet eligibility criteria, and 12 presented duplicate data. Thus, 35 prevalence papers of mood disorders met eligibility criteria for the review (17–19,23–54); 18 unique primary investigations of prevalence were included. The reasons for excluding prevalence studies fulfilling all but 1 of the inclusion criteria are documented in Table 2 (55–66). Of the 27 incidence studies identified, 22 were excluded: 16 did not meet inclusion criteria, and 6 were based on duplicate data. Therefore, 5 general population incidence studies of mood disorders were included (17,44,46,67,68). Five of the excluded studies almost met inclusion criteria, and reasons for their exclusion are presented in Table 2 (61,69–72).

Table 2  Mood disorder studies excluded at article review stage 

Study reference 

Reason for exclusion 

Comments 

General population studies 

 

 

Prevalence studies 

 

 

Mumford and others (66) 

Does not report prevalence rates 

Rates cannot be determined from data presented 

Angst (55) 

Does not meet age criteria 

Assesses age range of 22 to 35 years 

Takeuchi and others (57) 

Population too specific 

Looks at population of Chinese Americans  

Angst and Merikangas (56) 

Does not meet age criteria 

Only looks at ages 18 to 19 years 

Angst (58) 

Does not meet age criteria 

Prospective 10-year cohort study; presents rates applicable to age 20 to 30 years  

Rumble and others (59) 

Diagnoses based on ICD-8 criteria 

Community sample 

Fournier and Kovess (64) 

Not clear whether operationalized criteria used 

Comparison of mail and telephone surveys 

Stefansson and others (63) 

Does not include entire adult age group 

Presents rates applicable to age 55 to 57 years 

Surtees and Sashidharan (60) 

Limited to population of women 

Comparison of 2 community samples 

Dilling and Weyerer (62) 

Uses ICD-8 diagnostic criteria 

Community sample 

Halldin (65) 

Uses ICD-8 diagnostic criteria 

Community sample 

Shen and others (61) 

Diagnostic criteria used unclear 

Large community sample 

Incidence studies 

 

 

Murphy and others  (69) 

Does not use operationalized criteria 

Follow-up of cohort from 1970 to 1992 

Eaton and others (70) 

Based on duplicate data 

Looks at Baltimore site of ECA study with 12-year follow-up   

Horwath and others (71) 

Based on duplicate data 

Looks at 4 sites of ECA study with 1-year follow-up 

Rorsman and others  (72) 

Does not use operationalized criteria 

Study carried out between 1957 and 1972 

Shen and others (61) 

Diagnostic criteria used unclear 

Large community sample 

Primary care studies 

 

 

Prevalence studies 

 

 

Zinbarg and others (89) 

Inadequate sample size 

Examines both primary care and outpatient psychiatry populations 

Barrett and others (83) 

Does not use operationalized criteria 

Presents rates based on screening scales 

Kessler and others (84) 

Rates not representative of primary care population 

Denominator used in rate is total household population 

Schulberg and others (85) 

Rate may not be representative 

Overall response rate < 50% 

Parker and others (85) 

Rate may not be representative 

1st-stage response rate not assessed; very low 2nd-stage response rate 

Zung and others (87) 

Does not use operationalized criteria 

Presents rates based on screening scales 

Nielsen and Williams (88) 

Diagnoses based on Feighner (1972) criteria 

Data collected in 1971 

Primary Care Studies. For MDD in primary care, 9 prevalence and 2 incidence studies as well as 4 review papers were identified and retrieved. An additional 34 prevalence studies and 1 incidence study resulted from the reference lists of identified articles. Of the 43 prevalence studies identified, 33 were excluded as they did not fulfill inclusion criteria. Thus, 10 primary care prevalence studies met eligibility criteria for the review (73–82). Excluded studies almost meeting eligibility criteria are presented in Table 2 (83–89). Of the 3 incidence studies identified, 2 met eligibility criteria (90,91).

Prevalence Studies. We present findings for the 24 papers reporting overall or sex-specific 1-year and lifetime prevalence rates and age-specific lifetime prevalence rates for mood disorders in general, for MDD, for dysthymic disorder, and for BD I (Table 3 to 5, Figure 1). The results of 2 studies reporting only 1-year age-specific rates are not reported here (35,44). The results of studies reporting only data for point prevalence or 6-month prevalence (23,30,38–40,45,46) or for mood disorder categories other than those stated above (23,42,92) are also not presented.

Table 3  One-year prevalence rates of mood disorders 

Study authors 

Study site 

Total number of subjects (n) 

Response rate
(%) 

Case-finding method 

Prevalence rate (per 100 persons) 

 

 

 

 

 

Any mood disorder 

Major depressive disorder 

Dysthymic disorder 

Bipolar I disorder 

Henderson and others (32) 

Australia - national 

10 600 

78.0 

Census; CIDI-A/ICD-10; lay interviewers 

 

5.1 

1.1 

 

Bijl and others (18) 

Netherlands - national 

7146 

69.7 

Census; CIDI/DSM-III-R; lay interviewers; algorithm diagnosis 

7.6 

5.8 

2.3 

1.1 

Pakriev and others (17) 

Udmurt Republic - region of Udmurtia (rural areas) 

855 

85.9 

Census; CIDI/ICD-10 & DSM-III-R; diagnosis made by clinician 

 

22.5c 

15.4b 

4.1c 

2.6b 

0.1c 

0.2b 

Szadoczky and others (17) 

Hungary - national 

2953 

85.0 

Census (GP lists for 5 different areas); DIS/DSM-III-R; lay interviewers; algorithm diagnosis 

 

7.1 

 

0.9 

Offord and others (19) 

Canada - province of Ontario 

8116 

76.5 

Census; UM-CIDI/DSM-III-R; lay interviewers; algorithm diagnosis 

4.5 

4.1 

0.8 

0.6 

Kessler and others (36) 

USA (NCS) - national 

8098 

82.4 

Census; UM-CIDI/DSM-III-R; lay interviewers; algorithm diagnosis 

11.3 

10.3 

2.5 

1.3 

Bourdon and others (26) 

USA (ECA) - 5 sites, mainly urban 

20291 

68 to 80 

Census; DIS/DSM-III; lay interviewers; algorithm diagnosis 

6.3 

3.5 

3.3 

0.6 

Faravelli and others (54) 

Italy - 3 local health units of Florence 

1000 

100.0 

Census (GP lists for 3 local health units); structured interview including items from SADS-L; DSM-III & DSM-III-R; interviews by GPs 

 

— 

6.3a 

6.2b 

3.0a 

2.6b 

1.3a 

1.5b 

Oakley-
Browne and others (43) 

New Zealand - area of Christchurch, mostly urban 

1498 

70.0 

Census; DIS/DSM-III; lay interviewers; algorithm diagnosis 

10.4 

6.7 

 

0.2 

Hwu and others (34) 

Taiwan - 

metropolitan 

Taipei 

small towns 

rural villages 

11 004 

5 005 

— 

3 004 

2 995 

95.0 

— 

— 

— 

— 

Census; DIS-CM/DSM-III; lay interviewers; method of diagnosis unclear 

 

— 

0.64 

— 

1.1 

0.81 

 

— 

— 

— 

— 

— 

1.2 

— 

0.3 

1.0 

Bland and others (24) 

Canada - metropolitan Edmonton 

3 258 

71.6 

Census; DIS-DSM-III; lay interviewers; algorithm diagnosis 

6.8 

4.6 

 

0.2 

 

 

 

 

Best-estimate 

(95%CI) 

7.5 

(5.7 to 9.7) 

4.1 

(2.4 to 6.2) 

2.0 

(1.3 to 2.8) 

0.72 

(0.5 to 1.0) 

— = Not reported; aDSM-III criteria; bDSM-III-R criteria; cICD-10 criteria. 

CIDI-A = Composite International Diagnostic Interview ; CIDI/ICD = Composite International Diagnostic Interview/International Classification of Diseases;
DIS = Diagnostic Interview Schedule; DISCM =  Diagnostic Interview Schedule Chinese Modified; UM-CIDI = University of Michigan Composite International Diagnostic Interview. 


Because the diagnostic nomenclature for mood disorders has undergone revisions from DSM-III to DSM-IV criteria, it was necessary to make assumptions with respect to the classification of various terms in these studies to be in accordance with DSM-IV criteria. These terms, along with the DSM-IV categories to which they are assumed to be equivalent, are in Table 6.


Table 4  Lifetime prevalence rates of mood disorders 

Study authors 

Study site 

Total number of subjects (n

Response rate
(%) 

Case-finding method 

Prevalence rate (per 100 persons) 

         

Any mood disorder 

Major depressive disorder 

Dysthymic disorder 

Bipolar I disorder 

Murphy and others  (42) 

Atlantic Canada - region of Stirling County 

1 396 

86.0 

Census; DIS/DSM-III; lay interviewers; method of diagnosis unclear 

— 

7.9 

— 

— 

Bijl and others (18) 

Netherlands - national 

7 146 

69.7 

Census; CIDI/DSM-III-R; lay interviewers; algorithm diagnosis 

19.0 

15.4 

6.3 

1.8 

Szadoczky and others  (48) 

Hungary - national 

2 953 

85.0 

Census (GP lists for 5 different areas); DIS/DSM-III-R; lay interviewers; algorithm diagnosis 

24.2 

15.1 

4.5 

1.5 

Fournier and others  (31) 

Canada - Montreal 

893 

63.6 

Telephone survey; CIDIS/DSM-III-R; lay interviewers; algorithm diagnosis 

31.4 

29.6 

14.0 

— 

Carta and others  (28) 

Italy - Cagliari and Scano Montiferro   

480 

87.0 

Census; CIDI/DSM-III-R; physician interviewers 

— 

13.3 

4.1 

 

— 

Kessler and others  (36) 

USA (NCS) - national 

8 098 

82.4 

Census; UM-CIDI/DSM-III-R; lay interviewers; algorithm diagnosis 

19.3 

17.1 

6.4 

1.6 

Chen and others (29) 

Hong Kong - national 

7 229 

77.8 

Census; DIS-III-CM/DSM-III; lay interviewers; algorithm diagnosis 

— 

1.9a 

2.0a 

0.15a 

Wacker and others  (49) 

Switzerland - city of Basel 

470 

52.2 

Census; CIDI/DSM-III-R & ICD-10; interviewers with training in psychiatry or psychology 

19.4b 

25.7c 

15.7b 

22.8c 

7.2b 

7.0c 

— 

Bourdon and others  (26) 

USA (ECA) - 5 sites, mainly urban 

20 291 

68-80 

Census; DIS/DSM-III; lay interviewers; algorithm diagnosis 

8.3 

5.9 

3.3 

0.8 

Wittchen and others  (53) 

Germany - former West Germany 

483 

73.5 

Census; DIS/DSM-III; clinical interview and diagnosis 

12.9 

9.0 

4.0 

0.24 

Oakley-Browne and others (43) 

New Zealand - area of Christchurch, mostly urban 

1 498 

70.0 

Census; DIS/DSM-III; lay interviewers; algorithm diagnosis 

14.7 

12.6 

6.4 

0.7 

Hwu and others  (34) 

Taiwan 

  Metropolitan 

  Taipei 

  Small towns 

  Rural villages 

11 004 

5 005 

 

3 004 

2 995 

95.0 

Census; DIS-CM/DSM-III; lay interviewers; method of diagnosis unclear 

— 

— 

— 

— 

— 

— 

0.88 

— 

1.7 

0.97 

— 

0.92 

— 

1.5 

0.94 

— 

1.6 

— 

0.7 

1.0 

Bland and others (93) 

Canada - metropolitan Edmonton 

3 258 

71.6 

Census; DIS/DSM-III; lay interviewers; algorithm diagnosis 

10.2 

8.6 

3.7 

0.6 

Lee and others  (37) 

Korea - Dong, Seoul (urban) and Eub, Myeon (rural) 

5 100 

81.8 

Census; DIS/DSM-III; lay interviewers; algorithm diagnosis 

5.4 

3.4 

2.2 

0.42 

Canino and others (27) 

Puerto Rico - entire island nation 

1 513 

91 

Census; DIS/DSM-III; lay interviewers; algorithm diagnosis 

7.9 

4.6 

4.7 

0.5 

       

Best-estimate 

(95%CI) 

14.1 

(10.2 to 18.7) 

6.7 

(4.2 to 10.1) 

3.6 

(2.5 to 

5.0) 

0.82 

(0.56 to  1.1) 

aOverall rate calculated from raw data (only sex and age-specific rates reported); bDSM-III-R criteria; cICD-10 criteria; CIDI-S = CIDI simplified 


All the studies presented are community surveys using samples ranging in size from approximately 500 (49) to 20 000 (26) subjects. For each study, the percentage confidence interval (CI) width or error rate for estimated prevalence at a 95% confidence level may be calculated using the formula provided by Kelsey and colleagues (20, p 282). Most studies used either the Diagnostic Interview Schedule (DIS) or the Composite International Diagnostic Interview (CIDI) administered by trained lay interviewers and applied algorithms to derive diagnoses.


Table 5  Sex-specific 1-year and lifetime prevalence rates of mood disorders  

Study authors 

Study site 

Prevalence rate (per 100 persons) 

   

Any mood disorder 

Major depressive
disorder 

Dysthymic
disorder 

Bipolar I
disorder 

   

Male 

Female 

Male 

Female 

Male 

Female 

Male 

Female 

                   

1-year prevalence 

               

Henderson and others (32) 

Australia 

— 

— 

3.4 

6.8 

1.0 

1.3 

— 

— 

Bijl and others (18) 

Netherlands 

5.7 

9.7 

4.1 

7.5 

1.4 

3.2 

1.1 

1.1 

Pakriev and others (17) 

Udmurt Republic 

— 

— 

13.1 

29.6 

2.7 

5.1 

— 

— 

Szadoczky and others (48) 

Hungary 

— 

— 

4.7 

9.0 

— 

— 

1.0 

0.9 

Offord and others (19) 

Ontario, Canada 

3.2 

5.9 

2.8 

5.4 

a 

0.8 

a 

0.6 

Kessler and others  (36) 

USA (NCS) 

8.5 

14.1 

7.7 

12.9 

2.1 

3.0 

1.4 

1.3 

Faravelli and others (54) 

Florence, Italy 

— 

— 

3.5 

8.8 

2.2 

3.7 

0.7 

1.9 

Weissman and others  (51) 

USA (ECA) 

— 

— 

— 

— 

— 

— 

0.9 

1.1 

 

Best-estimate 

(95%CI)